Showing 8801-8810 of 9142 results for "".
- Sun Pharmaceutical to Buy DUSA Pharmaceuticalshttps://practicaldermatology.com/news/20121118-sun_pharmaceutical_to_buy_dusa_pharmaceuticals/2459678/Sun Pharmaceutical Industries Ltd. will buy DUSA Pharmaceuticals Inc. for about $215 million in cash, as the India-based company looks to make a foray into the lucrative market for dermatological treatments. The deal has been unanimously approved by the boards of both companies and DUSA's board has
- Allergan to Acquire SkinMedicahttps://practicaldermatology.com/news/20121116-allergan_to_acquire_skinmedica/2459680/Allergan, Inc. is set to acquire SkinMedica's topical aesthetics skin care business, in a deal estimated at approximately $350 million up-front. Allergan will also pay SkinMedica an additional $25 million contingent upon the acquired products achieving a specific level of net sales. The acquisition
- Dermatology Partnerships Exploredhttps://practicaldermatology.com/news/20121115-dermatology_partnerships_explored/2459681/Research and Markets has added the "Dermatology Partnering Terms and Agreements" report to their offering. This report provides a detailed understanding and analysis of how and why companies enter dermatology
- Belotero Now Available Nationwidehttps://practicaldermatology.com/news/20121106-ha-based_dermal-filler_released_by_merz/2459684/Belotero Balance, a dermal filler for the correction of moderate-to-severe facial wrinkles and folds, is now available nationwide from Merz Aesthetics. This dermal filler joins the Merz Aesthetics portfolio of injectable products, includin
- LEO Pharma's Taclonex Topical Suspension Approved for Body Plaqueshttps://practicaldermatology.com/news/20121029-leo_pharma_receives_fda_approval_for_taclonex_topical_suspension/2459689/LEO Pharma Inc. announced the US Food and Drug Administration (FDA) approval of Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064% for the treatment of body plaque psoriasis. Taclonex® Topical Suspension is
- Dermatologist Launches Rx Rebates, LLChttps://practicaldermatology.com/news/20121029-dermatologist_launches_rx_rebates_llc/2459690/Joel Bain Herron, MD, a dermatologist with Northeast Dermatology & Cosmetic Surgery Center, LLC in Gahanna, OH, founded Rx Rebates, LLC, a technology company. The website Rx_Rebates.com will be a mobile accessible site with a searchable database of digital versions of branded prescription rebate car
- Medical Entrepreneur Symposium Adds Breakout Sessionhttps://practicaldermatology.com/news/20121024-medical_entrepreneur_symposium_adds_breakout_session/2459693/The Medical Entrepreneur Symposium, a unique educational meeting for physicians, their office managers, and executives in healthcare, has added a breakout session for physician entrepreneurs wanting to take great business ideas or medical devices to market. Dr. Arlen Meyers will be the course direct
- ASDS Election Results Announcedhttps://practicaldermatology.com/news/20121023-asds_election_results_announced/2459696/The ASDS has elected new officers and members of its Board of Directors whose terms began at the recent annual meeting in Atlanta. Dr. George Hruza, Clinical Professor of Dermatology and Otolaryngology at St. Louis University, was elected Vice President and will ascend to President-Elect in 2013-14
- STELARA Wins 2012 International Prix Galien Awardhttps://practicaldermatology.com/news/20121022-stelara_wins_2012_international_prix_galien_award/2459698/Janssen Biotech, Inc. announced that STELARA was named the 2012 International Prix Galien award winner in Lyon, France. The honor is acknowledgment of the technical, scientific, and clinical research skills necessary to develop innovative medicines and devices. The international Prix Galien Award is
- Nuvo and Galderma Win FDA Approval for Topical Peelhttps://practicaldermatology.com/news/20121022-nuvo_and_galderma_win_fda_approval_for_topical_peel/2459699/Nuvo Research announced that the FDA has approved its Pliaglis product, a topical anesthetic cream designed to minimize pain during aesthetic dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. The approval